Patent details

EP3973987 Title: COMBINATION COMPRISING AN IL-4R ANTAGONIST, A CORTICOSTEROID AND A LONG-ACTING BETA2-ADRENERGIC AGONIST FOR TREATING ASTHMA

Basic Information

Publication number:
EP3973987
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP211911201
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION COMPRISING AN IL-4R ANTAGONIST, A CORTICOSTEROID AND A LONG-ACTING BETA2-ADRENERGIC AGONIST FOR TREATING ASTHMA
French Title of Invention:
COMBINAISON COMPRENANT UN ANTAGONISTE DE L'IL-4R, UN CORTICOSTÉROÏDE ET UN AGONISTE BÊTA2-ADRÉNERGIQUE À LONGUE DURÉE D'ACTION POUR LE TRAITEMENT DE L'ASTHME
German Title of Invention:
KOMBINATION AUS EINEM IL-4R-ANTAGONISTEN, EINEM KORTIKOSTEROID UND EINEM LANG WIRKENDEN BETA2-ADRENERGEN AGONISTEN ZUR BEHANDLUNG VON ASTHMA
SPC Number:

Dates

Filing date:
20/02/2015
Grant date:
10/01/2024
EP Publication Date:
30/03/2022
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/01/2024
EP B1 Publication Date:
10/01/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/02/2024
Expiration date:
20/02/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/01/2024
 
 

Name:
Regeneron Pharmaceuticals, Inc.
Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, United States (US)

Name:
Sanofi Biotechnology
Address:
82 Avenue Raspail, 94250 Gentilly, France (FR)

Inventor

1

Name:
PIROZZI, Gianluca
Address:
United States (US)

2

Name:
WEINSTEIN, Steven P.
Address:
United States (US)

3

Name:
SKOBIERANDA, Franck
Address:
United States (US)

4

Name:
GRAHAM, Neil
Address:
United States (US)

5

Name:
LI, Yongtao
Address:
United States (US)

Priority

1

Priority Number:
201461943019 P
Priority Date:
21/02/2014
Priority Country:
United States (US)

2

Priority Number:
14306413
Priority Date:
15/09/2014
Priority Country:
European Patent Office (EPO) (EP)

3

Priority Number:
201462077669 P
Priority Date:
10/11/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/395; A61K 31/00; A61K 31/167; A61K 31/56; A61P 11/06;

Publication

European Patent Bulletin

1

Issue number:
202402
Publication date:
10/01/2024
Description:
Grant (B1)

2

Issue number:
202407
Publication date:
14/02/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages